Which treatments are best for enlarged pores and acne scars?
The right treatment for pores and acne scars depends on the type of concern. Enlarged pores and textured scars often call for Sylfirm X Microneedling RF or Dermapen microneedling, while lingering redness may respond to V Laser Redness Treatment — the key is matching the approach to your skin's condition.
Matching the Approach to Your Type of Concern
"Pores and acne scars" covers a wide range of conditions. As a first step, it helps to identify which type your concern most closely resembles.
- 1Enlarged pores and uneven texture: RF-based treatments such as Sylfirm X Microneedling RF aim to stimulate skin renewal and tightening
- 2Indented (atrophic) acne scars: treatments that encourage skin regeneration, such as Dermapen microneedling or Pico Fractional Laser, may be considered
- 3Acne scars with lingering redness: V Laser Redness Treatment, which targets vascular redness, is one option
- 4Pigmented (dark) acne marks: pigment-targeting treatments such as Pico Toning may be considered
How Many Sessions, and Can Treatments Be Combined?
Rather than being a one-time fix, pore and acne scar care generally involves a series of sessions spaced at regular intervals, with progress monitored along the way. If you have a mix of concern types, we may combine treatments or plan the order strategically. How and when results appear varies from person to person.
What to Know Before Your Treatment
If you currently have a lot of active, inflamed acne, it may be better to treat the acne itself first. Rather than deciding on a treatment on your own, let us assess your skin during a consultation at PGC Clinic Shinjuku and build a realistic plan together. For fees, please see our Treatment Menu & Price Guide.
This content is general information; results and recovery vary from person to person. All treatments at our clinic are self-paid (not covered by public insurance). Where a treatment uses pharmaceuticals or devices not yet approved in Japan, details are provided on our Global Drug Advisory page.